Checking your sign-in status…

Private workspace

Finance

Research, portfolio tools, and market analysis in one place.

Finance home
Back to US Equities

US Equities · Finance research note

VRT — Vertiv

Research and analysis only
View analysis Browse US Equities

Evidence and analysis

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 16.36%
Profit Margins 14.37%
Return on Equity 45.1%
Return on Assets 11.15%
Free Float 0.38B
Dividend Yield 9.0%
Short Int % Utilisation 3.73%

2.2 Growth

Metric Value
Revenue Growth 30.1%
Free Cash Flow 1.96B
EBITDA 45.61 (Ratio)
Enterprise Value 108.69B
EV/Revenue 10.02
EV/EBITDA 45.61

Revenue growth of 30.1% places the company in a high-growth category.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* 174.16%
Risk / Std Dev (Ann.)* 65.22%
1-Year Price Return* 121.06%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $293.84
52-Week Range $118.70 – $379.94
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

DuPont Model Analysis

The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:

ROE = Net Margin × Asset Turnover × Equity Multiplier

The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in US$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.

DuPont component Calculation FY2025 FY2024
Revenue Reported revenue $10.23B $8.01B
Net income Reported net income $1.33B $495.80M
Total assets Year-end reported balance $12.21B $9.13B
Shareholders’ equity Year-end reported balance $3.94B $2.43B
Net margin Net income ÷ revenue 13.03% 6.19%
Asset turnover Revenue ÷ total assets 0.8377x 0.8773x
Equity multiplier Total assets ÷ shareholders’ equity 3.0986x 3.7516x
ROE Net margin × asset turnover × equity multiplier 33.82% 20.37%

Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating input Value
Revenue $10.23B
Prior annual revenue $8.01B
EBIT $1.83B
Tax rate 23.50%
NOPAT = EBIT × (1 − tax rate) $1.40B
Forecast start-growth basis 15.00%
Forecast policy latest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building block Value
NOPAT $1.40B
Add: depreciation & amortisation $308.60M
Less: capital expenditure -$226.40M
Less/(add): working-capital cash-flow movement $339.30M
Current unlevered FCFF $1.82B

Explicit FCFF forecast

Forecast year Revenue growth NOPAT D&A Capex Change in NWC FCFF Present value
1 15.00% $1.61B $354.89M -$260.36M $390.19M $2.09B $1.95B
2 11.88% $1.80B $397.03M -$317.72M $436.53M $2.32B $1.86B
3 8.75% $1.96B $431.77M -$374.27M $474.73M $2.49B $1.73B
4 5.62% $2.07B $456.06M -$425.69M $501.43M $2.60B $1.56B
5 2.50% $2.12B $467.46M -$467.46M $513.97M $2.63B $1.36B

Step 3 — Determine the Discount Rate (WACC)

WACC input Value
Risk-free rate 4.71%
Equity risk premium assumption 5.50%
Beta 2.08
Cost of equity 16.14%
Pre-tax cost of debt 2.70%
WACC 15.72%
WACC validation requires assumption review

Step 4 — Estimate Terminal Value

Terminal-value input Value
Perpetuity growth rate 2.50%
Terminal value $20.42B
Implied terminal EV / EBITDA 6.31x
Terminal value as % of enterprise value 53.78%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value component Value
Present value of explicit FCFF $8.46B
Present value of terminal value $9.84B
Indicated enterprise value $18.30B
Discounting convention mid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridge Value
Indicated enterprise value $18.30B
Less: gross interest-bearing debt $3.23B
Add: cash and equivalents $1.83B
Add: affiliate investments $0.00
Less: minority interests $0.00
Indicated common equity value $16.90B

Step 7 — Calculate Indicative Value Per Share

Per-share output Value
Shares used 390,652,824.00
Share-count basis reported diluted weighted-average shares
Current market price $272.23
DCF indicative value per share $43.26
Indicative value vs. market price -84.11%

Model Integrity Checks

Check Result
Perpetuity growth is below the risk-free rate pass
Perpetuity growth is below WACC pass
WACC is within the configured operating-company range review required
Terminal-year FCFF is positive pass
Terminal capex converges to D&A pass
Terminal-value concentration within review band
Implied price differs from spot by more than 30% review required

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 3/4 evidenced checks
Lynch-inspired balance-and-growth checks 4/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:53:35.112098 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

2.7 Quantitative Factor Diagnostics

Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.

Estimation input Value
Regional factor set US
Factor-return currency USD
Issuer-return basis USD adjusted total return
Estimation window 2025-08-19 to 2026-06-30
Aligned daily observations 217
Minimum observation requirement 120
Currency conversion for HK listings not required

Fama–French Three-Factor and Five-Factor Results

Diagnostic FF3 FF5
Annualised alpha 150.93% 93.89%
Adjusted R² 0.29 0.31
Annualised residual volatility 53.36% 52.09%
Factor loading (t-statistic) FF3 FF5
Market excess return (Mkt-RF) 2.57 (8.18) 2.04 (5.79)
Size (SMB) -0.88 (-2.07) -1.10 (-2.46)
Value (HML) -0.21 (-0.58) 0.08 (0.18)
Profitability (RMW) NM -1.17 (-3.12)
Investment (CMA) NM -0.09 (-0.14)

Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.

us-equitystockequityvrtindustrialselectrical-components--equipmentnasdaq